PharmaShots | Incisive News in 3 Shots

Subscribe Now

auto-inflammatory diseases

Bayer Signs a Research and License Agreement with Curadev to Develop Novel STING Antagonists Across Multiple Indications

Bayer Signs a Research and License Agreement with Curadev to Develop Novel STING Antagonists Across Multiple Indications

March 23, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us